APO Research, Inc.
Talk to an analyst

APO RESEARCH · REPORT

Human Cytomegalovirus Envelope Glycoprotein B

Compare research editions
View pricing & licenses

Selected research

Market Analysis & Forecast

Global Human Cytomegalovirus Envelope Glycoprotein B Market Analysis and Forecast 2026-2032

Report ID 173999620226 December 2025192 pages

Choose your research edition.

Industry ResearchHuman Cytomegalovirus Envelope Glycoprotein B Industry Research Report 2026122 pages · $2,950 USDIndustry Growth & TrendsGlobal Human Cytomegalovirus Envelope Glycoprotein B Industry Growth and Trends Forecast to 203299 pages · $3,450 USDMarket StructureGlobal Human Cytomegalovirus Envelope Glycoprotein B Market by Size, by Type, by Application, by Region, History and Forecast 2021-2032183 pages · $3,950 USDMarket Outlook & Growth OpportunitiesGlobal Human Cytomegalovirus Envelope Glycoprotein B Market Outlook and Growth Opportunities 2026193 pages · $4,250 USDMarket Analysis & ForecastGlobal Human Cytomegalovirus Envelope Glycoprotein B Market Analysis and Forecast 2026-2032192 pages · $4,950 USD

Market perspective

The global Human Cytomegalovirus Envelope Glycoprotein B market is projected to grow from US$ million in 2026 to US$ million by 2032, at a Compound Annual Growth Rate (CAGR) of % during the forecast period.

The US & Canada market for Human Cytomegalovirus Envelope Glycoprotein B is estimated to increase from $ million in 2026 to reach $ million by 2032, at a CAGR of % during the forecast period of 2026 through 2032.

Europe market for Human Cytomegalovirus Envelope Glycoprotein B is estimated to increase from $ million in 2026 to reach $ million by 2032, at a CAGR of % during the forecast period of 2026 through 2032.

Read the full market overview

Asia-Pacific market for Human Cytomegalovirus Envelope Glycoprotein B is estimated to increase from $ million in 2026 to reach $ million by 2032, at a CAGR of % during the forecast period of 2026 through 2032.

The China market for Human Cytomegalovirus Envelope Glycoprotein B is estimated to increase from $ million in 2026 to reach $ million by 2032, at a CAGR of % during the forecast period of 2026 through 2032.

The major global manufacturers of Human Cytomegalovirus Envelope Glycoprotein B include Vical Incorporated, VBI Vaccine Inc, Vakzine Projekt Management GmbH, Trellis Bioscience, Inc. and Astellas Pharma Inc., etc. In 2025, the world's top three vendors accounted for approximately % of the revenue.

This report presents an overview of global market for Human Cytomegalovirus Envelope Glycoprotein B, sales, revenue and price. Analyses of the global market trends, with historic market revenue or sales data for 2021 - 2025, estimates for 2026, and projections of CAGR through 2032.

This report researches the key producers of Human Cytomegalovirus Envelope Glycoprotein B, also provides the sales of main regions and countries. Of the upcoming market potential for Human Cytomegalovirus Envelope Glycoprotein B, and key regions or countries of focus to forecast this market into various segments and sub-segments. Country specific data and market value analysis for the U.S., Canada, Mexico, Brazil, China, Japan, South Korea, Southeast Asia, India, Germany, the U.K., Italy, Middle East, Africa, and Other Countries.

This report focuses on the Human Cytomegalovirus Envelope Glycoprotein B sales, revenue, market share and industry ranking of main manufacturers, data from 2021 to 2026. Identification of the major stakeholders in the global Human Cytomegalovirus Envelope Glycoprotein B market, and analysis of their competitive landscape and market positioning based on recent developments and segmental revenues. This report will help stakeholders to understand the competitive landscape and gain more insights and position their businesses and market strategies in a better way.

This report analyzes the segments data by Type and by Application, sales, revenue, and price, from 2021 to 2032. Evaluation and forecast the market size for Human Cytomegalovirus Envelope Glycoprotein B sales, projected growth trends, production technology, application and end-user industry.

Human Cytomegalovirus Envelope Glycoprotein B Segment by Company

Vical Incorporated

VBI Vaccine Inc

Vakzine Projekt Management GmbH

Trellis Bioscience, Inc.

Astellas Pharma Inc.

Human Cytomegalovirus Envelope Glycoprotein B Segment by Type

CSJ-148

CyMVectin

PPCM

TRL-345

Cytomegalovirus Vaccine

Others

Human Cytomegalovirus Envelope Glycoprotein B Segment by Application

Infectious Disease

Women's Health

Oncology

Others

Human Cytomegalovirus Envelope Glycoprotein B Segment by Region

North America

United States

Canada

Mexico

Europe

Germany

France

U.K.

Italy

Russia

Spain

Netherlands

Switzerland

Sweden

Poland

Asia-Pacific

China

Japan

South Korea

India

Australia

Taiwan

Southeast Asia

South America

Brazil

Argentina

Chile

Colombia

Middle East & Africa

Egypt

South Africa

Israel

Türkiye

GCC Countries

Study Objectives

1. To analyze and research the global status and future forecast, involving growth rate (CAGR), market share, historical and forecast.

2. To present the key manufacturers, sales, revenue, market share, and Recent Developments.

3. To split the breakdown data by regions, type, manufacturers, and Application.

4. To analyze the global and key regions market potential and advantage, opportunity and challenge, restraints, and risks.

5. To identify significant trends, drivers, influence factors in global and regions.

6. To analyze competitive developments such as expansions, agreements, new product launches, and acquisitions in the market.

Reasons to Buy This Report

1. This report will help the readers to understand the competition within the industries and strategies for the competitive environment to enhance the potential profit. The report also focuses on the competitive landscape of the global Human Cytomegalovirus Envelope Glycoprotein B market, and introduces in detail the market share, industry ranking, competitor ecosystem, market performance, new product development, operation situation, expansion, and acquisition. etc. of the main players, which helps the readers to identify the main competitors and deeply understand the competition pattern of the market.

2. This report will help stakeholders to understand the global industry status and trends of Human Cytomegalovirus Envelope Glycoprotein B and provides them with information on key market drivers, restraints, challenges, and opportunities.

3. This report will help stakeholders to understand competitors better and gain more insights to strengthen their position in their businesses. The competitive landscape section includes the market share and rank (in sales and value), competitor ecosystem, new product development, expansion, and acquisition.

4. This report stays updated with novel technology integration, features, and the latest developments in the market.

5. This report helps stakeholders to gain insights into which regions to target globally.

6. This report helps stakeholders to gain insights into the end-user perception concerning the adoption of Human Cytomegalovirus Envelope Glycoprotein B.

7. This report helps stakeholders to identify some of the key players in the market and understand their valuable contribution.

Chapter Outline

Chapter 1: Introduces the report scope of the report, executive summary of different market segments (by type and by application, etc), including the market size of each market segment, future development potential, and so on. It offers a high-level view of the current state of the market and its likely evolution in the short to mid-term, and long term.

Chapter 2: Introduces the market dynamics, latest developments of the market, the driving factors and restrictive factors of the market, the challenges and risks faced by manufacturers in the industry, and the analysis of relevant policies in the industry.

Chapter 3: Sales (consumption), revenue of Human Cytomegalovirus Envelope Glycoprotein B in global, regional level and country level. It provides a quantitative analysis of the market size and development potential of each region and its main countries and introduces the market development, future development prospects, market space of each country in the world.

Chapter 4: Detailed analysis of Human Cytomegalovirus Envelope Glycoprotein B manufacturers competitive landscape, price, sales, revenue, market share and industry ranking, latest development plan, merger, and acquisition information, etc.

Chapter 5: Provides the analysis of various market segments by type, covering the sales, revenue, average price, and development potential of each market segment, to help readers find the blue ocean market in different market segments.

Chapter 6: Provides the analysis of various market segments by application, covering the sales, revenue, average price, and development potential of each market segment, to help readers find the blue ocean market in different downstream markets.

Chapter 7: Provides profiles of key manufacturers, introducing the basic situation of the main companies in the market in detail, including product descriptions and specifications, Human Cytomegalovirus Envelope Glycoprotein B sales, revenue, price, gross margin, and recent development, etc.

Chapter 8: North America by type, by application and by country, sales, and revenue for each segment.

Chapter 9: Europe by type, by application and by country, sales, and revenue for each segment.

Chapter 10: China type, by application, sales, and revenue for each segment.

Chapter 11: Asia (excluding China) type, by application and by region, sales, and revenue for each segment.

Chapter 12: South America, Middle East and Africa by type, by application and by country, sales, and revenue for each segment.

Chapter 13: Analysis of industrial chain, sales channel, key raw materials, distributors and customers.

Chapter 14: The main concluding insights of the report.

More report detail

Tables and figures
List of Tables Table 1. Global Human Cytomegalovirus Envelope Glycoprotein B Market Size Growth Rate by Type (US$ Million), 2021 VS 2025 VS 2032 Table 2. CSJ-148 Major Manufacturers Table 3. CyMVectin Major Manufacturers Table 4. PPCM Major Manufacturers Table 5. TRL-345 Major Manufacturers Table 6. Cytomegalovirus Vaccine Major Manufacturers Table 7. Others Major Manufacturers Table 8. Global Human Cytomegalovirus Envelope Glycoprotein B Market Size Growth Rate by Application (US$ Million), 2021 VS 2025 VS 2032 Table 9. Infectious Disease Major Manufacturers Table 10. Women's Health Major Manufacturers Table 11. Oncology Major Manufacturers Table 12. Others Major Manufacturers Table 13. Human Cytomegalovirus Envelope Glycoprotein B Industry Trends Table 14. Human Cytomegalovirus Envelope Glycoprotein B Industry Drivers Table 15. Human Cytomegalovirus Envelope Glycoprotein B Industry Opportunities and Challenges Table 16. Human Cytomegalovirus Envelope Glycoprotein B Industry Restraints Table 17. Global Human Cytomegalovirus Envelope Glycoprotein B Revenue Grow Rate (CAGR) by Region: 2021 VS 2025 VS 2032 (US$ Million) Table 18. Global Human Cytomegalovirus Envelope Glycoprotein B Revenue by Region (2021-2026) & (US$ Million) Table 19. Global Human Cytomegalovirus Envelope Glycoprotein B Revenue by Region (2027-2032) & (US$ Million) Table 20. Global Human Cytomegalovirus Envelope Glycoprotein B Revenue Market Share by Region (2021-2026) Table 21. Global Human Cytomegalovirus Envelope Glycoprotein B Revenue Market Share by Region (2027-2032) Table 22. Global Human Cytomegalovirus Envelope Glycoprotein B Sales Grow Rate (CAGR) by Region: 2021 VS 2025 VS 2032 (W Units) Table 23. Global Human Cytomegalovirus Envelope Glycoprotein B Sales by Region (2021-2026) & (W Units) Table 24. Global Human Cytomegalovirus Envelope Glycoprotein B Sales by Region (2027-2032) & (W Units) Table 25. Global Human Cytomegalovirus Envelope Glycoprotein B Sales Market Share by Region (2021-2026) Table 26. Global Human Cytomegalovirus Envelope Glycoprotein B Sales Market Share by Region (2027-2032) Table 27. Global Human Cytomegalovirus Envelope Glycoprotein B Revenue by Manufacturers (US$ Million) & (2021-2026) Table 28. Global Human Cytomegalovirus Envelope Glycoprotein B Revenue Market Share by Manufacturers (2021-2026) Table 29. Global Human Cytomegalovirus Envelope Glycoprotein B Sales by Manufacturers (US$ Million) & (2021-2026) Table 30. Global Human Cytomegalovirus Envelope Glycoprotein B Sales Market Share by Manufacturers (2021-2026) Table 31. Global Human Cytomegalovirus Envelope Glycoprotein B Sales Price (US$/Unit) of Manufacturers (2021-2026) Table 32. Global Human Cytomegalovirus Envelope Glycoprotein B Key Manufacturers Ranking, 2024 VS 2025 VS 2026 Table 33. Global Human Cytomegalovirus Envelope Glycoprotein B Key Manufacturers Manufacturing Sites & Headquarters Table 34. Global Human Cytomegalovirus Envelope Glycoprotein B Manufacturers, Product Type & Application Table 35. Global Human Cytomegalovirus Envelope Glycoprotein B Manufacturers' Establishment Date Table 36. Global Manufacturers Market Concentration Ratio (CR5 and HHI) Table 37. Global Human Cytomegalovirus Envelope Glycoprotein B by Manufacturers Type (Tier 1, Tier 2, and Tier 3) & (Based on the Revenue of 2025) Table 38. Global Human Cytomegalovirus Envelope Glycoprotein B Revenue by Type 2021 VS 2025 VS 2032 (US$ Million) Table 39. Global Human Cytomegalovirus Envelope Glycoprotein B Revenue by Type (2021-2026) & (US$ Million) Table 40. Global Human Cytomegalovirus Envelope Glycoprotein B Revenue by Type (2027-2032) & (US$ Million) Table 41. Global Human Cytomegalovirus Envelope Glycoprotein B Revenue Market Share by Type (2021-2026) Table 42. Global Human Cytomegalovirus Envelope Glycoprotein B Revenue Market Share by Type (2027-2032) Table 43. Global Human Cytomegalovirus Envelope Glycoprotein B Sales by Type 2021 VS 2025 VS 2032 (W Units) Table 44. Global Human Cytomegalovirus Envelope Glycoprotein B Sales by Type (2021-2026) & (W Units) Table 45. Global Human Cytomegalovirus Envelope Glycoprotein B Sales by Type (2027-2032) & (W Units) Table 46. Global Human Cytomegalovirus Envelope Glycoprotein B Sales Market Share by Type (2021-2026) Table 47. Global Human Cytomegalovirus Envelope Glycoprotein B Sales Market Share by Type (2027-2032) Table 48. Global Human Cytomegalovirus Envelope Glycoprotein B Price by Type (2021-2026) & (US$/Unit) Table 49. Global Human Cytomegalovirus Envelope Glycoprotein B Price by Type (2027-2032) & (US$/Unit) Table 50. Global Human Cytomegalovirus Envelope Glycoprotein B Revenue by Application 2021 VS 2025 VS 2032 (US$ Million) Table 51. Global Human Cytomegalovirus Envelope Glycoprotein B Revenue by Application (2021-2026) & (US$ Million) Table 52. Global Human Cytomegalovirus Envelope Glycoprotein B Revenue by Application (2027-2032) & (US$ Million) Table 53. Global Human Cytomegalovirus Envelope Glycoprotein B Revenue Market Share by Application (2021-2026) Table 54. Global Human Cytomegalovirus Envelope Glycoprotein B Revenue Market Share by Application (2027-2032) Table 55. Global Human Cytomegalovirus Envelope Glycoprotein B Sales by Application 2021 VS 2025 VS 2032 (W Units) Table 56. Global Human Cytomegalovirus Envelope Glycoprotein B Sales by Application (2021-2026) & (W Units) Table 57. Global Human Cytomegalovirus Envelope Glycoprotein B Sales by Application (2027-2032) & (W Units) Table 58. Global Human Cytomegalovirus Envelope Glycoprotein B Sales Market Share by Application (2021-2026) Table 59. Global Human Cytomegalovirus Envelope Glycoprotein B Sales Market Share by Application (2027-2032) Table 60. Global Human Cytomegalovirus Envelope Glycoprotein B Price by Application (2021-2026) & (US$/Unit) Table 61. Global Human Cytomegalovirus Envelope Glycoprotein B Price by Application (2027-2032) & (US$/Unit) Table 62. Vical Incorporated Company Information Table 63. Vical Incorporated Business Overview Table 64. Vical Incorporated Human Cytomegalovirus Envelope Glycoprotein B Sales (W Units), Revenue (US$ Million), Price (US$/Unit) and Gross Margin (2021-2026) Table 65. Vical Incorporated Human Cytomegalovirus Envelope Glycoprotein B Product Portfolio Table 66. Vical Incorporated Recent Development Table 67. VBI Vaccine Inc Company Information Table 68. VBI Vaccine Inc Business Overview Table 69. VBI Vaccine Inc Human Cytomegalovirus Envelope Glycoprotein B Sales (W Units), Revenue (US$ Million), Price (US$/Unit) and Gross Margin (2021-2026) Table 70. VBI Vaccine Inc Human Cytomegalovirus Envelope Glycoprotein B Product Portfolio Table 71. VBI Vaccine Inc Recent Development Table 72. Vakzine Projekt Management GmbH Company Information Table 73. Vakzine Projekt Management GmbH Business Overview Table 74. Vakzine Projekt Management GmbH Human Cytomegalovirus Envelope Glycoprotein B Sales (W Units), Revenue (US$ Million), Price (US$/Unit) and Gross Margin (2021-2026) Table 75. Vakzine Projekt Management GmbH Human Cytomegalovirus Envelope Glycoprotein B Product Portfolio Table 76. Vakzine Projekt Management GmbH Recent Development Table 77. Trellis Bioscience, Inc. Company Information Table 78. Trellis Bioscience, Inc. Business Overview Table 79. Trellis Bioscience, Inc. Human Cytomegalovirus Envelope Glycoprotein B Sales (W Units), Revenue (US$ Million), Price (US$/Unit) and Gross Margin (2021-2026) Table 80. Trellis Bioscience, Inc. Human Cytomegalovirus Envelope Glycoprotein B Product Portfolio Table 81. Trellis Bioscience, Inc. Recent Development Table 82. Astellas Pharma Inc. Company Information Table 83. Astellas Pharma Inc. Business Overview Table 84. Astellas Pharma Inc. Human Cytomegalovirus Envelope Glycoprotein B Sales (W Units), Revenue (US$ Million), Price (US$/Unit) and Gross Margin (2021-2026) Table 85. Astellas Pharma Inc. Human Cytomegalovirus Envelope Glycoprotein B Product Portfolio Table 86. Astellas Pharma Inc. Recent Development Table 87. North America Human Cytomegalovirus Envelope Glycoprotein B Revenue by Type (2021-2026) & (US$ Million) Table 88. North America Human Cytomegalovirus Envelope Glycoprotein B Revenue by Type (2027-2032) & (US$ Million) Table 89. North America Human Cytomegalovirus Envelope Glycoprotein B Sales by Type (2021-2026) & (W Units) Table 90. North America Human Cytomegalovirus Envelope Glycoprotein B Sales by Type (2027-2032) & (W Units) Table 91. North America Human Cytomegalovirus Envelope Glycoprotein B Sales Price by Type (2021-2026) & (US$/Unit) Table 92. North America Human Cytomegalovirus Envelope Glycoprotein B Sales Price by Type (2027-2032) & (US$/Unit) Table 93. North America Human Cytomegalovirus Envelope Glycoprotein B Revenue by Application (2021-2026) & (US$ Million) Table 94. North America Human Cytomegalovirus Envelope Glycoprotein B Revenue by Application (2027-2032) & (US$ Million) Table 95. North America Human Cytomegalovirus Envelope Glycoprotein B Sales by Application (2021-2026) & (W Units) Table 96. North America Human Cytomegalovirus Envelope Glycoprotein B Sales by Application (2027-2032) & (W Units) Table 97. North America Human Cytomegalovirus Envelope Glycoprotein B Sales Price by Application (2021-2026) & (US$/Unit) Table 98. North America Human Cytomegalovirus Envelope Glycoprotein B Sales Price by Application (2027-2032) & (US$/Unit) Table 99. North America Human Cytomegalovirus Envelope Glycoprotein B Revenue Grow Rate by Country (2021 VS 2025 VS 2032) & (US$ Million) Table 100. North America Human Cytomegalovirus Envelope Glycoprotein B Revenue Grow Rate by Country (2021-2026) & (US$ Million) Table 101. North America Human Cytomegalovirus Envelope Glycoprotein B Revenue Grow Rate by Country (2027-2032) & (US$ Million) Table 102. North America Human Cytomegalovirus Envelope Glycoprotein B Sales by Country (2021 VS 2025 VS 2032) & (W Units) Table 103. North America Human Cytomegalovirus Envelope Glycoprotein B Sales by Country (2021-2026) & (W Units) Table 104. North America Human Cytomegalovirus Envelope Glycoprotein B Sales by Country (2027-2032) & (W Units) Table 105. North America Human Cytomegalovirus Envelope Glycoprotein B Sales Price by Country (2021-2026) & (US$/Unit) Table 106. North America Human Cytomegalovirus Envelope Glycoprotein B Sales Price by Country (2027-2032) & (US$/Unit) Table 107. United States Human Cytomegalovirus Envelope Glycoprotein B Revenue (2021-2032) & (US$ Million) Table 108. Canada Human Cytomegalovirus Envelope Glycoprotein B Revenue (2021-2032) & (US$ Million) Table 109. Mexico Human Cytomegalovirus Envelope Glycoprotein B Revenue (2021-2032) & (US$ Million) Table 110. Europe Human Cytomegalovirus Envelope Glycoprotein B Revenue by Type (2021-2026) & (US$ Million) Table 111. Europe Human Cytomegalovirus Envelope Glycoprotein B Revenue by Type (2027-2032) & (US$ Million) Table 112. Europe Human Cytomegalovirus Envelope Glycoprotein B Sales by Type (2021-2026) & (W Units) Table 113. Europe Human Cytomegalovirus Envelope Glycoprotein B Sales by Type (2027-2032) & (W Units) Table 114. Europe Human Cytomegalovirus Envelope Glycoprotein B Sales Price by Type (2021-2026) & (US$/Unit) Table 115. Europe Human Cytomegalovirus Envelope Glycoprotein B Sales Price by Type (2027-2032) & (US$/Unit) Table 116. Europe Human Cytomegalovirus Envelope Glycoprotein B Revenue by Application (2021-2026) & (US$ Million) Table 117. Europe Human Cytomegalovirus Envelope Glycoprotein B Revenue by Application (2027-2032) & (US$ Million) Table 118. Europe Human Cytomegalovirus Envelope Glycoprotein B Sales by Application (2021-2026) & (W Units) Table 119. Europe Human Cytomegalovirus Envelope Glycoprotein B Sales by Application (2027-2032) & (W Units) Table 120. Europe Human Cytomegalovirus Envelope Glycoprotein B Sales Price by Application (2021-2026) & (US$/Unit) Table 121. Europe Human Cytomegalovirus Envelope Glycoprotein B Sales Price by Application (2027-2032) & (US$/Unit) Table 122. Europe Human Cytomegalovirus Envelope Glycoprotein B Revenue Grow Rate by Country (2021 VS 2025 VS 2032) & (US$ Million) Table 123. Europe Human Cytomegalovirus Envelope Glycoprotein B Revenue Grow Rate by Country (2021-2026) & (US$ Million) Table 124. Europe Human Cytomegalovirus Envelope Glycoprotein B Revenue Grow Rate by Country (2027-2032) & (US$ Million) Table 125. Europe Human Cytomegalovirus Envelope Glycoprotein B Sales by Country (2021 VS 2025 VS 2032) & (W Units) Table 126. Europe Human Cytomegalovirus Envelope Glycoprotein B Sales by Country (2021-2026) & (W Units) Table 127. Europe Human Cytomegalovirus Envelope Glycoprotein B Sales by Country (2027-2032) & (W Units) Table 128. Europe Human Cytomegalovirus Envelope Glycoprotein B Sales Price by Country (2021-2026) & (US$/Unit) Table 129. Europe Human Cytomegalovirus Envelope Glycoprotein B Sales Price by Country (2027-2032) & (US$/Unit) Table 130. Germany Human Cytomegalovirus Envelope Glycoprotein B Revenue (2021-2032) & (US$ Million) Table 131. France Human Cytomegalovirus Envelope Glycoprotein B Revenue (2021-2032) & (US$ Million) Table 132. U.K. Human Cytomegalovirus Envelope Glycoprotein B Revenue (2021-2032) & (US$ Million) Table 133. Italy Human Cytomegalovirus Envelope Glycoprotein B Revenue (2021-2032) & (US$ Million) Table 134. Russia Human Cytomegalovirus Envelope Glycoprotein B Revenue (2021-2032) & (US$ Million) Table 135. Spain Human Cytomegalovirus Envelope Glycoprotein B Revenue (2021-2032) & (US$ Million) Table 136. Netherlands Human Cytomegalovirus Envelope Glycoprotein B Revenue (2021-2032) & (US$ Million) Table 137. Switzerland Human Cytomegalovirus Envelope Glycoprotein B Revenue (2021-2032) & (US$ Million) Table 138. Sweden Human Cytomegalovirus Envelope Glycoprotein B Revenue (2021-2032) & (US$ Million) Table 139. Poland Human Cytomegalovirus Envelope Glycoprotein B Revenue (2021-2032) & (US$ Million) Table 140. China Human Cytomegalovirus Envelope Glycoprotein B Revenue by Type (2021-2026) & (US$ Million) Table 141. China Human Cytomegalovirus Envelope Glycoprotein B Revenue by Type (2027-2032) & (US$ Million) Table 142. China Human Cytomegalovirus Envelope Glycoprotein B Sales by Type (2021-2026) & (W Units) Table 143. China Human Cytomegalovirus Envelope Glycoprotein B Sales by Type (2027-2032) & (W Units) Table 144. China Human Cytomegalovirus Envelope Glycoprotein B Sales Price by Type (2021-2026) & (US$/Unit) Table 145. China Human Cytomegalovirus Envelope Glycoprotein B Sales Price by Type (2027-2032) & (US$/Unit) Table 146. China Human Cytomegalovirus Envelope Glycoprotein B Revenue by Application (2021-2026) & (US$ Million) Table 147. China Human Cytomegalovirus Envelope Glycoprotein B Revenue by Application (2027-2032) & (US$ Million) Table 148. China Human Cytomegalovirus Envelope Glycoprotein B Sales by Application (2021-2026) & (W Units) Table 149. China Human Cytomegalovirus Envelope Glycoprotein B Sales by Application (2027-2032) & (W Units) Table 150. China Human Cytomegalovirus Envelope Glycoprotein B Sales Price by Application (2021-2026) & (US$/Unit) Table 151. China Human Cytomegalovirus Envelope Glycoprotein B Sales Price by Application (2027-2032) & (US$/Unit) Table 152. Asia Human Cytomegalovirus Envelope Glycoprotein B Revenue by Type (2021-2026) & (US$ Million) Table 153. Asia Human Cytomegalovirus Envelope Glycoprotein B Revenue by Type (2027-2032) & (US$ Million) Table 154. Asia Human Cytomegalovirus Envelope Glycoprotein B Sales by Type (2021-2026) & (W Units) Table 155. Asia Human Cytomegalovirus Envelope Glycoprotein B Sales by Type (2027-2032) & (W Units) Table 156. Asia Human Cytomegalovirus Envelope Glycoprotein B Sales Price by Type (2021-2026) & (US$/Unit) Table 157. Asia Human Cytomegalovirus Envelope Glycoprotein B Sales Price by Type (2027-2032) & (US$/Unit) Table 158. Asia Human Cytomegalovirus Envelope Glycoprotein B Revenue by Application (2021-2026) & (US$ Million) Table 159. Asia Human Cytomegalovirus Envelope Glycoprotein B Revenue by Application (2027-2032) & (US$ Million) Table 160. Asia Human Cytomegalovirus Envelope Glycoprotein B Sales by Application (2021-2026) & (W Units) Table 161. Asia Human Cytomegalovirus Envelope Glycoprotein B Sales by Application (2027-2032) & (W Units) Table 162. Asia Human Cytomegalovirus Envelope Glycoprotein B Sales Price by Application (2021-2026) & (US$/Unit) Table 163. Asia Human Cytomegalovirus Envelope Glycoprotein B Sales Price by Application (2027-2032) & (US$/Unit) Table 164. Asia Human Cytomegalovirus Envelope Glycoprotein B Revenue Grow Rate by Country (2021 VS 2025 VS 2032) & (US$ Million) Table 165. Asia Human Cytomegalovirus Envelope Glycoprotein B Revenue Grow Rate by Country (2021-2026) & (US$ Million) Table 166. Asia Human Cytomegalovirus Envelope Glycoprotein B Revenue Grow Rate by Country (2027-2032) & (US$ Million) Table 167. Asia Human Cytomegalovirus Envelope Glycoprotein B Sales by Country (2021 VS 2025 VS 2032) & (W Units) Table 168. Asia Human Cytomegalovirus Envelope Glycoprotein B Sales by Country (2021-2026) & (W Units) Table 169. Asia Human Cytomegalovirus Envelope Glycoprotein B Sales by Country (2027-2032) & (W Units) Table 170. Asia Human Cytomegalovirus Envelope Glycoprotein B Sales Price by Country (2021-2026) & (US$/Unit) Table 171. Asia Human Cytomegalovirus Envelope Glycoprotein B Sales Price by Country (2027-2032) & (US$/Unit) Table 172. Japan Human Cytomegalovirus Envelope Glycoprotein B Revenue (2021-2032) & (US$ Million) Table 173. South Korea Human Cytomegalovirus Envelope Glycoprotein B Revenue (2021-2032) & (US$ Million) Table 174. India Human Cytomegalovirus Envelope Glycoprotein B Revenue (2021-2032) & (US$ Million) Table 175. Australia Human Cytomegalovirus Envelope Glycoprotein B Revenue (2021-2032) & (US$ Million) Table 176. Taiwan Human Cytomegalovirus Envelope Glycoprotein B Revenue (2021-2032) & (US$ Million) Table 177. Southeast Asia Human Cytomegalovirus Envelope Glycoprotein B Revenue (2021-2032) & (US$ Million) Table 178. SAMEA Human Cytomegalovirus Envelope Glycoprotein B Revenue by Type (2021-2026) & (US$ Million) Table 179. SAMEA Human Cytomegalovirus Envelope Glycoprotein B Revenue by Type (2027-2032) & (US$ Million) Table 180. SAMEA Human Cytomegalovirus Envelope Glycoprotein B Sales by Type (2021-2026) & (W Units) Table 181. SAMEA Human Cytomegalovirus Envelope Glycoprotein B Sales by Type (2027-2032) & (W Units) Table 182. SAMEA Human Cytomegalovirus Envelope Glycoprotein B Sales Price by Type (2021-2026) & (US$/Unit) Table 183. SAMEA Human Cytomegalovirus Envelope Glycoprotein B Sales Price by Type (2027-2032) & (US$/Unit) Table 184. SAMEA Human Cytomegalovirus Envelope Glycoprotein B Revenue by Application (2021-2026) & (US$ Million) Table 185. SAMEA Human Cytomegalovirus Envelope Glycoprotein B Revenue by Application (2027-2032) & (US$ Million) Table 186. SAMEA Human Cytomegalovirus Envelope Glycoprotein B Sales by Application (2021-2026) & (W Units) Table 187. SAMEA Human Cytomegalovirus Envelope Glycoprotein B Sales by Application (2027-2032) & (W Units) Table 188. SAMEA Human Cytomegalovirus Envelope Glycoprotein B Sales Price by Application (2021-2026) & (US$/Unit) Table 189. SAMEA Human Cytomegalovirus Envelope Glycoprotein B Sales Price by Application (2027-2032) & (US$/Unit) Table 190. SAMEA Human Cytomegalovirus Envelope Glycoprotein B Revenue Grow Rate by Country (2021 VS 2025 VS 2032) & (US$ Million) Table 191. SAMEA Human Cytomegalovirus Envelope Glycoprotein B Revenue Grow Rate by Country (2021-2026) & (US$ Million) Table 192. SAMEA Human Cytomegalovirus Envelope Glycoprotein B Revenue Grow Rate by Country (2027-2032) & (US$ Million) Table 193. SAMEA Human Cytomegalovirus Envelope Glycoprotein B Sales by Country (2021 VS 2025 VS 2032) & (W Units) Table 194. SAMEA Human Cytomegalovirus Envelope Glycoprotein B Sales by Country (2021-2026) & (W Units) Table 195. SAMEA Human Cytomegalovirus Envelope Glycoprotein B Sales by Country (2027-2032) & (W Units) Table 196. SAMEA Human Cytomegalovirus Envelope Glycoprotein B Sales Price by Country (2021-2026) & (US$/Unit) Table 197. SAMEA Human Cytomegalovirus Envelope Glycoprotein B Sales Price by Country (2027-2032) & (US$/Unit) Table 198. Brazil Human Cytomegalovirus Envelope Glycoprotein B Revenue (2021-2032) & (US$ Million) Table 199. Argentina Human Cytomegalovirus Envelope Glycoprotein B Revenue (2021-2032) & (US$ Million) Table 200. Chile Human Cytomegalovirus Envelope Glycoprotein B Revenue (2021-2032) & (US$ Million) Table 201. Colombia Human Cytomegalovirus Envelope Glycoprotein B Revenue (2021-2032) & (US$ Million) Table 202. Peru Human Cytomegalovirus Envelope Glycoprotein B Revenue (2021-2032) & (US$ Million) Table 203. Saudi Arabia Human Cytomegalovirus Envelope Glycoprotein B Revenue (2021-2032) & (US$ Million) Table 204. Israel Human Cytomegalovirus Envelope Glycoprotein B Revenue (2021-2032) & (US$ Million) Table 205. UAE Human Cytomegalovirus Envelope Glycoprotein B Revenue (2021-2032) & (US$ Million) Table 206. Turkey Human Cytomegalovirus Envelope Glycoprotein B Revenue (2021-2032) & (US$ Million) Table 207. Iran Human Cytomegalovirus Envelope Glycoprotein B Revenue (2021-2032) & (US$ Million) Table 208. Egypt Human Cytomegalovirus Envelope Glycoprotein B Revenue (2021-2032) & (US$ Million) Table 209. Key Raw Materials Table 210. Raw Materials Key Suppliers Table 211. Human Cytomegalovirus Envelope Glycoprotein B Distributors List Table 212. Human Cytomegalovirus Envelope Glycoprotein B Customers List Table 213. Research Programs/Design for This Report Table 214. Authors List of This Report Table 215. Secondary Sources Table 216. Primary Sources List of Figures Figure 1. Human Cytomegalovirus Envelope Glycoprotein B Image Figure 2. Global Human Cytomegalovirus Envelope Glycoprotein B Market Size Growth Rate by Type (US$ Million), 2021 VS 2025 VS 2032 Figure 3. Global Human Cytomegalovirus Envelope Glycoprotein B Market Size Share 2021 VS 2025 VS 2032 Figure 4. CSJ-148 Image Figure 5. CyMVectin Image Figure 6. PPCM Image Figure 7. TRL-345 Image Figure 8. Cytomegalovirus Vaccine Image Figure 9. Others Image Figure 10. Global Human Cytomegalovirus Envelope Glycoprotein B Market Size Growth Rate by Application (US$ Million), 2021 VS 2025 VS 2032 Figure 11. Global Human Cytomegalovirus Envelope Glycoprotein B Market Size Share 2021 VS 2025 VS 2032 Figure 12. Infectious Disease Image Figure 13. Women's Health Image Figure 14. Oncology Image Figure 15. Others Image Figure 16. Global Human Cytomegalovirus Envelope Glycoprotein B Revenue (US$ Million), 2021 VS 2025 VS 2032 Figure 17. Global Human Cytomegalovirus Envelope Glycoprotein B Revenue (2021-2032) & (US$ Million) Figure 18. Global Human Cytomegalovirus Envelope Glycoprotein B Revenue (CAGR) by Region: 2021 VS 2025 VS 2032 (US$ Million) Figure 19. Global Human Cytomegalovirus Envelope Glycoprotein B Revenue Market Share by Region: 2025 Versus 2032 Figure 20. Global Human Cytomegalovirus Envelope Glycoprotein B Revenue Market Share by Region (2021-2032) Figure 21. Global Human Cytomegalovirus Envelope Glycoprotein B Sales (2021-2032) & (W Units) Figure 22. Global Human Cytomegalovirus Envelope Glycoprotein B Sales by Region: 2021 VS 2025 VS 2032 (W Units) Figure 23. Global Human Cytomegalovirus Envelope Glycoprotein B Sales Market Share by Region (2021-2032) Figure 24. US & Canada & Mexico Human Cytomegalovirus Envelope Glycoprotein B Sales YoY (2021-2032) & (W Units) Figure 25. Europe Human Cytomegalovirus Envelope Glycoprotein B Sales YoY (2021-2032) & (W Units) Figure 26. China Human Cytomegalovirus Envelope Glycoprotein B Sales YoY (2021-2032) & (W Units) Figure 27. Asia (Excluding China) Human Cytomegalovirus Envelope Glycoprotein B Sales YoY (2021-2032) & (W Units) Figure 28. South America, Middle East and Africa Human Cytomegalovirus Envelope Glycoprotein B Sales YoY (2021-2032) & (W Units) Figure 29. Global Human Cytomegalovirus Envelope Glycoprotein B Manufacturers Revenue Share Top 10 and Top 5 in 2025 Figure 30. Global Human Cytomegalovirus Envelope Glycoprotein B Manufacturers Sales Share Top 10 and Top 5 in 2025 Figure 31. Manufacturers Type (Tier 1, Tier 2, and Tier 3): 2021 VS 2025 Figure 32. Global Human Cytomegalovirus Envelope Glycoprotein B Revenue by Type (2021 VS 2025 VS 2032) & (US$ Million) Figure 33. Global Human Cytomegalovirus Envelope Glycoprotein B Revenue Market Share by Type 2021 VS 2025 VS 2032 Figure 34. Global Human Cytomegalovirus Envelope Glycoprotein B Revenue Market Share by Type (2021-2032) Figure 35. Global Human Cytomegalovirus Envelope Glycoprotein B Sales by Type (2021 VS 2025 VS 2032) & (W Units) Figure 36. Global Human Cytomegalovirus Envelope Glycoprotein B Sales Market Share by Type 2021 VS 2025 VS 2032 Figure 37. Global Human Cytomegalovirus Envelope Glycoprotein B Sales Market Share by Type (2021-2032) Figure 38. Global Human Cytomegalovirus Envelope Glycoprotein B Revenue by Application (2021 VS 2025 VS 2032) & (US$ Million) Figure 39. Global Human Cytomegalovirus Envelope Glycoprotein B Revenue Market Share by Application 2021 VS 2025 VS 2032 Figure 40. Global Human Cytomegalovirus Envelope Glycoprotein B Revenue Market Share by Application (2021-2032) Figure 41. Global Human Cytomegalovirus Envelope Glycoprotein B Sales by Application (2021 VS 2025 VS 2032) & (W Units) Figure 42. Global Human Cytomegalovirus Envelope Glycoprotein B Sales Market Share by Application 2021 VS 2025 VS 2032 Figure 43. Global Human Cytomegalovirus Envelope Glycoprotein B Sales Market Share by Application (2021-2032) Figure 44. North America Human Cytomegalovirus Envelope Glycoprotein B Revenue Share by Type (2021-2032) Figure 45. North America Human Cytomegalovirus Envelope Glycoprotein B Sales Share by Type (2021-2032) Figure 46. North America Human Cytomegalovirus Envelope Glycoprotein B Revenue Share by Application (2021-2032) Figure 47. North America Human Cytomegalovirus Envelope Glycoprotein B Sales Share by Application (2021-2032) Figure 48. North America Human Cytomegalovirus Envelope Glycoprotein B Revenue Share by Country (2021-2032) Figure 49. North America Human Cytomegalovirus Envelope Glycoprotein B Sales Share by Country (2021-2032) Figure 50. Europe Human Cytomegalovirus Envelope Glycoprotein B Revenue Share by Type (2021-2032) Figure 51. Europe Human Cytomegalovirus Envelope Glycoprotein B Sales Share by Type (2021-2032) Figure 52. Europe Human Cytomegalovirus Envelope Glycoprotein B Revenue Share by Application (2021-2032) Figure 53. Europe Human Cytomegalovirus Envelope Glycoprotein B Sales Share by Application (2021-2032) Figure 54. Europe Human Cytomegalovirus Envelope Glycoprotein B Revenue Share by Country (2021-2032) Figure 55. Europe Human Cytomegalovirus Envelope Glycoprotein B Sales Share by Country (2021-2032) Figure 56. China Human Cytomegalovirus Envelope Glycoprotein B Revenue Share by Type (2021-2032) Figure 57. China Human Cytomegalovirus Envelope Glycoprotein B Sales Share by Type (2021-2032) Figure 58. China Human Cytomegalovirus Envelope Glycoprotein B Revenue Share by Application (2021-2032) Figure 59. China Human Cytomegalovirus Envelope Glycoprotein B Sales Share by Application (2021-2032) Figure 60. Asia Human Cytomegalovirus Envelope Glycoprotein B Revenue Share by Type (2021-2032) Figure 61. Asia Human Cytomegalovirus Envelope Glycoprotein B Sales Share by Type (2021-2032) Figure 62. Asia Human Cytomegalovirus Envelope Glycoprotein B Revenue Share by Application (2021-2032) Figure 63. Asia Human Cytomegalovirus Envelope Glycoprotein B Sales Share by Application (2021-2032) Figure 64. Asia Human Cytomegalovirus Envelope Glycoprotein B Revenue Share by Country (2021-2032) Figure 65. Asia Human Cytomegalovirus Envelope Glycoprotein B Sales Share by Country (2021-2032) Figure 66. SAMEA Human Cytomegalovirus Envelope Glycoprotein B Revenue Share by Type (2021-2032) Figure 67. SAMEA Human Cytomegalovirus Envelope Glycoprotein B Sales Share by Type (2021-2032) Figure 68. SAMEA Human Cytomegalovirus Envelope Glycoprotein B Revenue Share by Application (2021-2032) Figure 69. SAMEA Human Cytomegalovirus Envelope Glycoprotein B Sales Share by Application (2021-2032) Figure 70. SAMEA Human Cytomegalovirus Envelope Glycoprotein B Revenue Share by Country (2021-2032) Figure 71. SAMEA Human Cytomegalovirus Envelope Glycoprotein B Sales Share by Country (2021-2032) Figure 72. Human Cytomegalovirus Envelope Glycoprotein B Value Chain Figure 73. Manufacturing Cost Structure Figure 74. Human Cytomegalovirus Envelope Glycoprotein B Production Mode & Process Figure 75. Direct Comparison with Distribution Share Figure 76. Distributors Profiles Figure 77. Years Considered Figure 78. Research Process Figure 79. Key Executives Interviewed

Scope & coverage.

Types
  • CSJ-148
  • CyMVectin
  • PPCM
  • TRL-345
  • Cytomegalovirus Vaccine
  • Others
Applications
  • Infectious Disease
  • Women's Health
  • Oncology
  • Others
Companies covered
  • Vical Incorporated
  • VBI Vaccine Inc
  • Vakzine Projekt Management GmbH
  • Trellis Bioscience, Inc.
  • Astellas Pharma Inc.

Inside the report.

1 Market Overview
  1. 1.1 Product Definition
  2. 1.2 Human Cytomegalovirus Envelope Glycoprotein B Market by Type
  3. 1.2.1 Global Human Cytomegalovirus Envelope Glycoprotein B Market Size by Type, 2021 VS 2025 VS 2032
  4. 1.2.2 CSJ-148
  5. 1.2.3 CyMVectin
  6. 1.2.4 PPCM
  7. 1.2.5 TRL-345
  8. 1.2.6 Cytomegalovirus Vaccine
  9. 1.2.7 Others
  10. 1.3 Human Cytomegalovirus Envelope Glycoprotein B Market by Application
  11. 1.3.1 Global Human Cytomegalovirus Envelope Glycoprotein B Market Size by Application, 2021 VS 2025 VS 2032
  12. 1.3.2 Infectious Disease
  13. 1.3.3 Women's Health
  14. 1.3.4 Oncology
  15. 1.3.5 Others
  16. 1.4 Assumptions and Limitations
  17. 1.5 Study Goals and Objectives
2 Human Cytomegalovirus Envelope Glycoprotein B Market Dynamics
  1. 2.1 Human Cytomegalovirus Envelope Glycoprotein B Industry Trends
  2. 2.2 Human Cytomegalovirus Envelope Glycoprotein B Industry Drivers
  3. 2.3 Human Cytomegalovirus Envelope Glycoprotein B Industry Opportunities and Challenges
  4. 2.4 Human Cytomegalovirus Envelope Glycoprotein B Industry Restraints
3 Global Market Growth Prospects
  1. 3.1 Global Human Cytomegalovirus Envelope Glycoprotein B Revenue Estimates and Forecasts (2021-2032)
  2. 3.2 Global Human Cytomegalovirus Envelope Glycoprotein B Revenue by Region
  3. 3.2.1 Global Human Cytomegalovirus Envelope Glycoprotein B Revenue by Region: 2021 VS 2025 VS 2032
  4. 3.2.2 Global Human Cytomegalovirus Envelope Glycoprotein B Revenue by Region (2021-2026)
  5. 3.2.3 Global Human Cytomegalovirus Envelope Glycoprotein B Revenue by Region (2027-2032)
  6. 3.2.4 Global Human Cytomegalovirus Envelope Glycoprotein B Revenue Market Share by Region (2021-2032)
  7. 3.3 Global Human Cytomegalovirus Envelope Glycoprotein B Sales Estimates and Forecasts 2021-2032
  8. 3.4 Global Human Cytomegalovirus Envelope Glycoprotein B Sales by Region
  9. 3.4.1 Global Human Cytomegalovirus Envelope Glycoprotein B Sales by Region: 2021 VS 2025 VS 2032
  10. 3.4.2 Global Human Cytomegalovirus Envelope Glycoprotein B Sales by Region (2021-2026)
  11. 3.4.3 Global Human Cytomegalovirus Envelope Glycoprotein B Sales by Region (2027-2032)
  12. 3.4.4 Global Human Cytomegalovirus Envelope Glycoprotein B Sales Market Share by Region (2021-2032)
  13. 3.5 US & Canada & Mexico
  14. 3.6 Europe
  15. 3.7 China
  16. 3.8 Asia (Excluding China)
  17. 3.9 South America, Middle East and Africa
4 Market Competitive Landscape by Manufacturers
  1. 4.1 Global Human Cytomegalovirus Envelope Glycoprotein B Revenue by Manufacturers
  2. 4.1.1 Global Human Cytomegalovirus Envelope Glycoprotein B Revenue by Manufacturers (2021-2026)
  3. 4.1.2 Global Human Cytomegalovirus Envelope Glycoprotein B Revenue Market Share by Manufacturers (2021-2026)
  4. 4.1.3 Global Human Cytomegalovirus Envelope Glycoprotein B Manufacturers Revenue Share Top 10 and Top 5 in 2025
  5. 4.2 Global Human Cytomegalovirus Envelope Glycoprotein B Sales by Manufacturers
  6. 4.2.1 Global Human Cytomegalovirus Envelope Glycoprotein B Sales by Manufacturers (2021-2026)
  7. 4.2.2 Global Human Cytomegalovirus Envelope Glycoprotein B Sales Market Share by Manufacturers (2021-2026)
  8. 4.2.3 Global Human Cytomegalovirus Envelope Glycoprotein B Manufacturers Sales Share Top 10 and Top 5 in 2025
  9. 4.3 Global Human Cytomegalovirus Envelope Glycoprotein B Sales Price by Manufacturers (2021-2026)
  10. 4.4 Global Human Cytomegalovirus Envelope Glycoprotein B Key Manufacturers Ranking, 2024 VS 2025 VS 2026
  11. 4.5 Global Human Cytomegalovirus Envelope Glycoprotein B Key Manufacturers Manufacturing Sites & Headquarters
  12. 4.6 Global Human Cytomegalovirus Envelope Glycoprotein B Manufacturers, Product Type & Application
  13. 4.7 Global Human Cytomegalovirus Envelope Glycoprotein B Manufacturers' Establishment Date
  14. 4.8 Market Competitive Analysis
  15. 4.8.1 Global Human Cytomegalovirus Envelope Glycoprotein B Market CR5 and HHI
  16. 4.8.2 2025 Human Cytomegalovirus Envelope Glycoprotein B Tier 1, Tier 2, and Tier 3
5 Human Cytomegalovirus Envelope Glycoprotein B Market by Type
  1. 5.1 Global Human Cytomegalovirus Envelope Glycoprotein B Revenue by Type
  2. 5.1.1 Global Human Cytomegalovirus Envelope Glycoprotein B Revenue by Type (2021 VS 2025 VS 2032)
  3. 5.1.2 Global Human Cytomegalovirus Envelope Glycoprotein B Revenue by Type (2021-2032) & (US$ Million)
  4. 5.1.3 Global Human Cytomegalovirus Envelope Glycoprotein B Revenue Market Share by Type (2021-2032)
  5. 5.2 Global Human Cytomegalovirus Envelope Glycoprotein B Sales by Type
  6. 5.2.1 Global Human Cytomegalovirus Envelope Glycoprotein B Sales by Type (2021 VS 2025 VS 2032)
  7. 5.2.2 Global Human Cytomegalovirus Envelope Glycoprotein B Sales by Type (2021-2032) & (W Units)
  8. 5.2.3 Global Human Cytomegalovirus Envelope Glycoprotein B Sales Market Share by Type (2021-2032)
  9. 5.3 Global Human Cytomegalovirus Envelope Glycoprotein B Price by Type
6 Human Cytomegalovirus Envelope Glycoprotein B Market by Application
  1. 6.1 Global Human Cytomegalovirus Envelope Glycoprotein B Revenue by Application
  2. 6.1.1 Global Human Cytomegalovirus Envelope Glycoprotein B Revenue by Application (2021 VS 2025 VS 2032)
  3. 6.1.2 Global Human Cytomegalovirus Envelope Glycoprotein B Revenue by Application (2021-2032) & (US$ Million)
  4. 6.1.3 Global Human Cytomegalovirus Envelope Glycoprotein B Revenue Market Share by Application (2021-2032)
  5. 6.2 Global Human Cytomegalovirus Envelope Glycoprotein B Sales by Application
  6. 6.2.1 Global Human Cytomegalovirus Envelope Glycoprotein B Sales by Application (2021 VS 2025 VS 2032)
  7. 6.2.2 Global Human Cytomegalovirus Envelope Glycoprotein B Sales by Application (2021-2032) & (W Units)
  8. 6.2.3 Global Human Cytomegalovirus Envelope Glycoprotein B Sales Market Share by Application (2021-2032)
  9. 6.3 Global Human Cytomegalovirus Envelope Glycoprotein B Price by Application
7 Company Profiles
  1. 7.1 Vical Incorporated
  2. 7.1.1 Vical Incorporated Company Information
  3. 7.1.2 Vical Incorporated Business Overview
  4. 7.1.3 Vical Incorporated Human Cytomegalovirus Envelope Glycoprotein B Sales, Revenue, Price and Gross Margin (2021-2026)
  5. 7.1.4 Vical Incorporated Human Cytomegalovirus Envelope Glycoprotein B Product Portfolio
  6. 7.1.5 Vical Incorporated Recent Developments
  7. 7.2 VBI Vaccine Inc
  8. 7.2.1 VBI Vaccine Inc Company Information
  9. 7.2.2 VBI Vaccine Inc Business Overview
  10. 7.2.3 VBI Vaccine Inc Human Cytomegalovirus Envelope Glycoprotein B Sales, Revenue, Price and Gross Margin (2021-2026)
  11. 7.2.4 VBI Vaccine Inc Human Cytomegalovirus Envelope Glycoprotein B Product Portfolio
  12. 7.2.5 VBI Vaccine Inc Recent Developments
  13. 7.3 Vakzine Projekt Management GmbH
  14. 7.3.1 Vakzine Projekt Management GmbH Company Information
  15. 7.3.2 Vakzine Projekt Management GmbH Business Overview
  16. 7.3.3 Vakzine Projekt Management GmbH Human Cytomegalovirus Envelope Glycoprotein B Sales, Revenue, Price and Gross Margin (2021-2026)
  17. 7.3.4 Vakzine Projekt Management GmbH Human Cytomegalovirus Envelope Glycoprotein B Product Portfolio
  18. 7.3.5 Vakzine Projekt Management GmbH Recent Developments
  19. 7.4 Trellis Bioscience, Inc.
  20. 7.4.1 Trellis Bioscience, Inc. Company Information
  21. 7.4.2 Trellis Bioscience, Inc. Business Overview
  22. 7.4.3 Trellis Bioscience, Inc. Human Cytomegalovirus Envelope Glycoprotein B Sales, Revenue, Price and Gross Margin (2021-2026)
  23. 7.4.4 Trellis Bioscience, Inc. Human Cytomegalovirus Envelope Glycoprotein B Product Portfolio
  24. 7.4.5 Trellis Bioscience, Inc. Recent Developments
  25. 7.5 Astellas Pharma Inc.
  26. 7.5.1 Astellas Pharma Inc. Company Information
  27. 7.5.2 Astellas Pharma Inc. Business Overview
  28. 7.5.3 Astellas Pharma Inc. Human Cytomegalovirus Envelope Glycoprotein B Sales, Revenue, Price and Gross Margin (2021-2026)
  29. 7.5.4 Astellas Pharma Inc. Human Cytomegalovirus Envelope Glycoprotein B Product Portfolio
  30. 7.5.5 Astellas Pharma Inc. Recent Developments
8 North America
  1. 8.1 North America Human Cytomegalovirus Envelope Glycoprotein B Market Size by Type
  2. 8.1.1 North America Human Cytomegalovirus Envelope Glycoprotein B Revenue by Type (2021-2032)
  3. 8.1.2 North America Human Cytomegalovirus Envelope Glycoprotein B Sales by Type (2021-2032)
  4. 8.1.3 North America Human Cytomegalovirus Envelope Glycoprotein B Price by Type (2021-2032)
  5. 8.2 North America Human Cytomegalovirus Envelope Glycoprotein B Market Size by Application
  6. 8.2.1 North America Human Cytomegalovirus Envelope Glycoprotein B Revenue by Application (2021-2032)
  7. 8.2.2 North America Human Cytomegalovirus Envelope Glycoprotein B Sales by Application (2021-2032)
  8. 8.2.3 North America Human Cytomegalovirus Envelope Glycoprotein B Price by Application (2021-2032)
  9. 8.3 North America Human Cytomegalovirus Envelope Glycoprotein B Market Size by Country
  10. 8.3.1 North America Human Cytomegalovirus Envelope Glycoprotein B Revenue Grow Rate by Country (2021 VS 2025 VS 2032)
  11. 8.3.2 North America Human Cytomegalovirus Envelope Glycoprotein B Sales by Country (2021 VS 2025 VS 2032)
  12. 8.3.3 North America Human Cytomegalovirus Envelope Glycoprotein B Price by Country (2021-2032)
  13. 8.3.4 United States
  14. 8.3.5 Canada
  15. 8.3.6 Mexico
9 Europe
  1. 9.1 Europe Human Cytomegalovirus Envelope Glycoprotein B Market Size by Type
  2. 9.1.1 Europe Human Cytomegalovirus Envelope Glycoprotein B Revenue by Type (2021-2032)
  3. 9.1.2 Europe Human Cytomegalovirus Envelope Glycoprotein B Sales by Type (2021-2032)
  4. 9.1.3 Europe Human Cytomegalovirus Envelope Glycoprotein B Price by Type (2021-2032)
  5. 9.2 Europe Human Cytomegalovirus Envelope Glycoprotein B Market Size by Application
  6. 9.2.1 Europe Human Cytomegalovirus Envelope Glycoprotein B Revenue by Application (2021-2032)
  7. 9.2.2 Europe Human Cytomegalovirus Envelope Glycoprotein B Sales by Application (2021-2032)
  8. 9.2.3 Europe Human Cytomegalovirus Envelope Glycoprotein B Price by Application (2021-2032)
  9. 9.3 Europe Human Cytomegalovirus Envelope Glycoprotein B Market Size by Country
  10. 9.3.1 Europe Human Cytomegalovirus Envelope Glycoprotein B Revenue Grow Rate by Country (2021 VS 2025 VS 2032)
  11. 9.3.2 Europe Human Cytomegalovirus Envelope Glycoprotein B Sales by Country (2021 VS 2025 VS 2032)
  12. 9.3.3 Europe Human Cytomegalovirus Envelope Glycoprotein B Price by Country (2021-2032)
  13. 9.3.4 Germany
  14. 9.3.5 France
  15. 9.3.6 U.K.
  16. 9.3.7 Italy
  17. 9.3.8 Russia
  18. 9.3.9 Spain
  19. 9.3.10 Netherlands
10 China
  1. 10.1 China Human Cytomegalovirus Envelope Glycoprotein B Market Size by Type
  2. 10.1.1 China Human Cytomegalovirus Envelope Glycoprotein B Revenue by Type (2021-2032)
  3. 10.1.2 China Human Cytomegalovirus Envelope Glycoprotein B Sales by Type (2021-2032)
  4. 10.1.3 China Human Cytomegalovirus Envelope Glycoprotein B Price by Type (2021-2032)
  5. 10.2 China Human Cytomegalovirus Envelope Glycoprotein B Market Size by Application
  6. 10.2.1 China Human Cytomegalovirus Envelope Glycoprotein B Revenue by Application (2021-2032)
  7. 10.2.2 China Human Cytomegalovirus Envelope Glycoprotein B Sales by Application (2021-2032)
  8. 10.2.3 China Human Cytomegalovirus Envelope Glycoprotein B Price by Application (2021-2032)
11 Asia (Excluding China)
  1. 11.1 Asia Human Cytomegalovirus Envelope Glycoprotein B Market Size by Type
  2. 11.1.1 Asia Human Cytomegalovirus Envelope Glycoprotein B Revenue by Type (2021-2032)
  3. 11.1.2 Asia Human Cytomegalovirus Envelope Glycoprotein B Sales by Type (2021-2032)
  4. 11.1.3 Asia Human Cytomegalovirus Envelope Glycoprotein B Price by Type (2021-2032)
  5. 11.2 Asia Human Cytomegalovirus Envelope Glycoprotein B Market Size by Application
  6. 11.2.1 Asia Human Cytomegalovirus Envelope Glycoprotein B Revenue by Application (2021-2032)
  7. 11.2.2 Asia Human Cytomegalovirus Envelope Glycoprotein B Sales by Application (2021-2032)
  8. 11.2.3 Asia Human Cytomegalovirus Envelope Glycoprotein B Price by Application (2021-2032)
  9. 11.3 Asia Human Cytomegalovirus Envelope Glycoprotein B Market Size by Country
  10. 11.3.1 Asia Human Cytomegalovirus Envelope Glycoprotein B Revenue Grow Rate by Country (2021 VS 2025 VS 2032)
  11. 11.3.2 Asia Human Cytomegalovirus Envelope Glycoprotein B Sales by Country (2021 VS 2025 VS 2032)
  12. 11.3.3 Asia Human Cytomegalovirus Envelope Glycoprotein B Price by Country (2021-2032)
  13. 11.3.4 Japan
  14. 11.3.5 South Korea
  15. 11.3.6 India
  16. 11.3.7 Australia
  17. 11.3.8 Taiwan
  18. 11.3.9 Southeast Asia
12 South America, Middle East and Africa
  1. 12.1 SAMEA Human Cytomegalovirus Envelope Glycoprotein B Market Size by Type
  2. 12.1.1 SAMEA Human Cytomegalovirus Envelope Glycoprotein B Revenue by Type (2021-2032)
  3. 12.1.2 SAMEA Human Cytomegalovirus Envelope Glycoprotein B Sales by Type (2021-2032)
  4. 12.1.3 SAMEA Human Cytomegalovirus Envelope Glycoprotein B Price by Type (2021-2032)
  5. 12.2 SAMEA Human Cytomegalovirus Envelope Glycoprotein B Market Size by Application
  6. 12.2.1 SAMEA Human Cytomegalovirus Envelope Glycoprotein B Revenue by Application (2021-2032)
  7. 12.2.2 SAMEA Human Cytomegalovirus Envelope Glycoprotein B Sales by Application (2021-2032)
  8. 12.2.3 SAMEA Human Cytomegalovirus Envelope Glycoprotein B Price by Application (2021-2032)
  9. 12.3 SAMEA Human Cytomegalovirus Envelope Glycoprotein B Market Size by Country
  10. 12.3.1 SAMEA Human Cytomegalovirus Envelope Glycoprotein B Revenue Grow Rate by Country (2021 VS 2025 VS 2032)
  11. 12.3.2 SAMEA Human Cytomegalovirus Envelope Glycoprotein B Sales by Country (2021 VS 2025 VS 2032)
  12. 12.3.3 SAMEA Human Cytomegalovirus Envelope Glycoprotein B Price by Country (2021-2032)
  13. 12.3.4 Brazil
  14. 12.3.5 Argentina
  15. 12.3.6 Chile
  16. 12.3.7 Colombia
  17. 12.3.8 Peru
  18. 12.3.9 Saudi Arabia
  19. 12.3.10 Israel
  20. 12.3.11 UAE
  21. 12.3.12 Turkey
  22. 12.3.13 Iran
  23. 12.3.14 Egypt
13 Value Chain and Sales Channels Analysis
  1. 13.1 Human Cytomegalovirus Envelope Glycoprotein B Value Chain Analysis
  2. 13.1.1 Human Cytomegalovirus Envelope Glycoprotein B Key Raw Materials
  3. 13.1.2 Raw Materials Key Suppliers
  4. 13.1.3 Manufacturing Cost Structure
  5. 13.1.4 Human Cytomegalovirus Envelope Glycoprotein B Production Mode & Process
  6. 13.2 Human Cytomegalovirus Envelope Glycoprotein B Sales Channels Analysis
  7. 13.2.1 Direct Comparison with Distribution Share
  8. 13.2.2 Human Cytomegalovirus Envelope Glycoprotein B Distributors
  9. 13.2.3 Human Cytomegalovirus Envelope Glycoprotein B Customers
14 Concluding Insights
    15 Appendix
    1. 15.1 Reasons for Doing This Study
    2. 15.2 Research Methodology
    3. 15.3 Research Process
    4. 15.4 Authors List of This Report
    5. 15.5 Data Source
    6. 15.5.1 Secondary Sources
    7. 15.5.2 Primary Sources
    8. 15.6 Disclaimer

    GET THE RESEARCH

    Choose your license.

    Choose who needs access.
    All options are for this report and research series.

    Compare access permissions.

    Single User License
    One named user. Individual access.
    Multi User License
    Up to 5 users in the same department.
    Enterprise License
    Organization-wide access within the agreed license.

    Access applies to the purchased edition. Later editions are separate purchases.

    License options
    $4,950USD
    Buy now

    PDF by email within 3–5 working days after payment confirmation.

    Talk to an analyst
    APO Research, Inc.
    Talk to an analyst